Dr. Slawomir L. Malendowicz, MD

Dr. Malendowicz practices at Slawomir Malendowicz MD in Yonkers, New York.

Dr. Malendowicz's NPI, 1407862998, was assigned on August 1, 2006. Dr. Malendowicz holds New York license 206325-1.

Dr. Malendowicz's primary practice is Slawomir Malendowicz MD, at 944 N Broadway, Yonkers, NY 10701 in Westchester County. The practice phone is (914) 423-8118.

Dr. Malendowicz's primary practice is Slawomir Malendowicz MD in Yonkers, New York. Dr. Malendowicz is also affiliated with St. John's Riverside Hospital. The medical group on file is Cardiology Associates of Westchester. Dmand AI also links Dr. Malendowicz to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Malendowicz practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Malendowicz's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Malendowicz is licensed in New York.

CMS data shows 2,742 Medicare services from Dr. Malendowicz across 22 procedure codes in 2024, for 388 Medicare patients. Medicare paid $301,581 for them.

CMS counts 388 Medicare patients who saw Dr. Malendowicz in 2024. The largest group is 75 to 84, with 143 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Malendowicz's median patient age at 69, with 56% women.

In 2024, Dr. Malendowicz wrote 516 Medicare Part D claims for 99 patients. 95% of them were for generic drugs. CMS names the drug for 454 of them, across 9 drugs with 11 or more claims each, at $12,435 in total drug cost. In 2023, CMS named 343 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Malendowicz for performance year 2024, reported individually. Dr. Malendowicz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 39 general payments to Dr. Malendowicz from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $2,525.